24613-61-4 Usage
General Description
Phosphoric acid oleyl ester is a type of ester compound formed from the reaction of oleyl alcohol and phosphoric acid. This chemical is commonly used as a surfactant in various industrial applications, including in the production of cleaning products, emulsifiers, and corrosion inhibitors. It is also utilized as a lubricant and anti-foaming agent in the manufacturing of paints, coatings, and polymer products. Phosphoric acid oleyl ester is known for its ability to lower the surface tension of liquids, allowing for better dispersion of substances and improved wetting properties. Additionally, it can function as a thickening agent in cosmetics and personal care products. Due to its versatile and useful properties, this chemical is an important ingredient in various industrial and consumer products.
Check Digit Verification of cas no
The CAS Registry Mumber 24613-61-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,6,1 and 3 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 24613-61:
(7*2)+(6*4)+(5*6)+(4*1)+(3*3)+(2*6)+(1*1)=94
94 % 10 = 4
So 24613-61-4 is a valid CAS Registry Number.
InChI:InChI=1/C18H37O4P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22-23(19,20)21/h9-10H,2-8,11-18H2,1H3,(H2,19,20,21)/b10-9-
24613-61-4Relevant articles and documents
The oxorhenium(VII)-catalyzed direct condensation of phosphoric acid with an alcohol
Sakakura, Akira,Katsukawa, Mikimoto,Ishihara, Kazuaki
, p. 1423 - 1426 (2007)
(Chemical Equation Presented) Come together ... over Re: Oxorhenium-(VII) complexes catalyze the direct condensation of phosphoric acid with an alcohol to selectively give the corresponding phosphoric acid monoester on a 2-100-mmol scale (see scheme). This method should be useful for the industrially important synthesis of phosphoric acid monoesters.
LPA RECEPTOR AGONISTS AND ANTAGONISTS AND METHODS OF USE
-
Page/Page column 37-38, (2008/06/13)
The present invention relates to compounds according to formula (I) as disclosed herein as well as pharmaceutical compositions which include those compounds. Also disclosed are methods of using such compounds, which have activity as agonists or as antagonists of LPA receptors; such methods including inhibiting LPA activity on an LPA receptor, modulating LPA receptor activity, treating cancer, enhancing cell proliferation, treating a wound, treating apoptosis or preserving or restoring function in a cell, tissue, or ogan, culturing cells, preserving organ or tissue function, and treating a dermatological condition.
